A satellite meeting at the start of IAS 2025 introduced important new WHO guidelines on long-acting injectable PrEP and significant updates to other important aspects of HIV care.
The session was introduced by Meg Doherty, Director of Global HIV, Hepatitis and STIs at WHO and recently appointed Director of Science, Research and Evidence and Quality for Health. The guidelines have been designed to support simplification, greater integration and better use of limited resources with a focus on people from key populations and others who are often left behind.
The session included main presentations on each section followed by an open Q&A discussion.
Read the full news story at HIV i-Base.
All HIV i-Base reports from IAS 2025 can be accessed here.
Source : HIV i-Base
Related HIV and Co-Infections News
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.